Commercial Field of Use definition

Commercial Field of Use means the marketing, sale and provision of Omics Services on a fee basis to Institutional Customers, in each case, for use in connection with the information provided to an Institutional Customer. For the avoidance of doubt, the “Commercial Field of Use” does not include Omics Services provided primarily for research or educational purposes or for consumer applications or primarily for the discovery, development, evaluation, trial, analysis or regulatory approval of any pharmaceutical or therapeutic product or treatment, or any companion diagnostic, biomarker, neoantigen or neoepitope.
Sample 1Sample 2Sample 3
Commercial Field of Use means the prophylaxis, palliation, diagnosis and treatment of the Initial Indications and Additional Indications by Products via any route of administration.
Sample 1
Commercial Field of Use means the discovery, development, manufacture, marketing and selling of diagnostic products and therapeutic products.
Sample 1

Examples of Commercial Field of Use in a sentence

  • Subject to the restrictions and obligations set forth in this Agreement, NantOmics hereby appoints NantHealth, during the Term, as an exclusive reseller of the Omics Services in and for the Commercial Field of Use, with the exclusive right to market and sell Omics Services in the Territory to and for Institutional Customers in and for the Commercial Field of Use.

  • Furthermore and for the avoidance of doubt, NantOmics expressly reserves, and NantHealth may not exercise, any and all rights with respect to the Omics Services outside the Commercial Field of Use.

  • For the avoidance of doubt, the foregoing exclusivity does not apply, and NantOmics reserves the right to offer and make Omics Services available, outside the Commercial Field of Use.

  • Accordingly, during the Term and except to the extent otherwise agreed by the Parties on a case-by-case basis, NantOmics will not provide or otherwise make available Omics Services to other Persons in or for the Commercial Field of Use and will not authorize or grant any other Person the right to market or sell Omics Services in or for the Commercial Field of Use.

  • Subject to the terms of this Agreement, Genaissance shall grant WSU a [**], non-exclusive worldwide license[**] under Genaissance Patent Rights and Genaissance Know-How to use any HAP Marker in a HAP Marker Association solely in the Commercial Field of Use.

  • Novartis has the exclusive right (the "Commercialization Option") during the Option Term to license exclusively any and all IMO Candidates, including, without limitation, IMO Leads, for commercialization of Products in the Commercial Field of Use, under the terms and conditions set forth in the License Agreement.

  • Notwithstanding the foregoing, Novartis shall not have the right to expand the Commercial Field of Use to include oncology indications, non-human indications, or infectious disease indications not originally included in the Commercial Field of Use.

  • If Hybridon withholds its consent to the requested expansion because, as of the date on which Hybridon receives the Option Notice, Hybridon is actively negotiating with a Third Party to grant exclusive rights to the Additional Indication(s), but Hybridon does not grant such rights to such Third Party within [**] after the receipt of the Option Notice, Hybridon shall agree to the expansion of the Commercial Field of Use to include such Additional Indication(s).

  • During the term of this License Agreement, Hybridon shall neither grant to any Third Party rights to any immunomodulatory oligonucleotide other than Excluded Antisense IP in the Commercial Field of Use, nor shall Hybridon develop or commercialize, directly or indirectly, any immunomodulatory oligonucleotide other than Excluded Antisense IP in the Commercial Field of Use.

  • If Novartis generates pre-clinical data that supports the inclusion of Additional Indication(s) in the Commercial Field of Use, Novartis may notify Hybridon that it wishes to include such Additional Indication(s) in the Commercial Field of Use at any time after the second anniversary of the Effective Date of the Collaboration Agreement (the "Option Notice").

Related to Commercial Field of Use

  • Licensed Field of Use means all fields.

  • Field of Use means all fields of use.

  • Licensed Field means [***].

  • Licensed Fields of Use means the fields of use identified in Appendix B.

  • Licensed Territory means worldwide.

  • Licensed Technology means the Licensed Patents and the Licensed Know-How.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Exclusive Field means the diagnosis, treatment or prevention of any cancer in humans through the use of Engineered T-Cells, which shall exclude the diagnosis, treatment or prevention of medullary cystic kidney disease 1 regardless of whether such disease is characterized as a cancer.

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Light field means that area of the intersection of the light beam from the beam-limiting device and one of the set of planes parallel to and including the plane of the image receptor, whose perimeter is the locus of points at which the illumination is one-fourth of the maximum in the intersection.

  • Licensed Know-How means any and all unpatented and/or non-patentable technical data, documents, materials, samples and other information and know‐how that is Controlled by LICENSOR or any of its Affiliates as of the Effective Date or thereafter during the Term that relates to, or is otherwise reasonably necessary or reasonably useful for, the use, Development, manufacture, or Commercialization of the Product. Licensed Know-How shall not include Licensed Patents.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Competing Product means [***].

  • Competing Products means any product or service in existence or under development that competes with any product or service of the Company Group about which the Participant obtained Confidential Information or for which the Participant provided advisory services or had sales, origination, marketing, production, distribution, research or development responsibilities in the last twenty-four (24) months of employment with the Company Group.

  • Product Technology means the Product Know-How and Product Patents.

  • Licensor Technology means the Licensor Patents, the Licensor Know-How, Licensor Materials, and Non-Patent Rights Controlled by Licensor or its Affiliates embodied in Licensor Know-How or Licensor Materials.

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Research Use shall have the meaning given in Section 2.2.2 of this Agreement.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Commercialize or “Commercialization” means the marketing, promotion, sale (and offer for sale or contract to sell), distribution, importation or other commercial exploitation (including pricing and reimbursement activities) for a Product in the Territory. Commercialization shall include commercial activities conducted in preparation for Product launch.

  • Licensed Patents means (a) all United States patents and patent applications listed in Exhibit A, as modified pursuant to Section 2.6.1, including patents arising from such patent applications; and (b) any re-examination certificates thereof, and their foreign counterparts and extensions, continuations, divisionals, and re-issue applications; provided that “Licensed Patents” will not include any claim of a patent or patent application covering any Manufacturing Technology.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Licensee Technology means the Licensee Know-How and Licensee Patents.

  • Third Party Technology means all Intellectual Property and products owned by third parties and licensed pursuant to Third Party Licenses.

  • Manufacturing Technology means any and all patents, patent applications, know-how, and all intellectual property rights associated therewith that are owned or controlled by Licensor, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno-associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.